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SUPPLEMENTAL MATERIAL 
 
Methods 
Scenario 1 
When 𝐷2 is the time to event, it includes two variables (𝑇, 𝛿), where 𝑇 is the time to event and 𝛿 
is the indicator of non-censoring. We generate 𝑇 from the proportional hazards regression 
model (3), where λ(𝑇|𝐺, 𝑋) is the hazard function with risk factors of 𝐺 and 𝑋 and 2𝑇 is an 
arbitrary baseline hazard function. We generate 𝛿 from the uniform distribution 𝑈(0, 𝜏), where 𝜏 
is chosen to yield the fixed proportion 𝑐2 of non-censored subsequent events.  
 
Scenario 2 
We simulate 𝑍 with a normal distribution of mean 𝜂𝐺 and variance 1. We set 𝜂 to 0.354 and 
0.514 to represent that 5% and 10% variance of 𝑍 is explained by 𝐺.  
 
Calculation of the true marginal association 
The true marginal association (i.e., HR or OR) of 𝐺 on 𝐷2 in scenario 1 can be calculated by the 
following counterfactual method. First, we generate a sample of the general population with 
values on 𝐺, 𝑋, and 𝐷1; the sample size is large, here 200,000,000 (so that the “new dataset” 
defined below will be sufficiently large for estimating the true marginal association with ignorable 
variation). We then obtain the subset with 𝐷1 = 1 when the target population is population 2, or 
the subset with 𝐷1 = 1 and 𝑆 = 1 when the target population is population 3. In either case, we 
denote the subset by 𝒜. Let 𝑁 be the sample size of 𝒜. Second, we create a new dataset that 
consists of three sets of samples, each of size 𝑁. We generate the first set of samples by taking 
all subjects in 𝒜, replacing their values of 𝐺 by 0, and generating 𝐷2 based on the original 
values of 𝑋 and the new values of 𝐺. We generate the second and third sets of samples 
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similarly except that we set all 𝐺's to be 1 and 2, respectively. Finally, we calculate the 
association estimate using the new values of 𝐺 and 𝐷2 in the new dataset. This way, we obtain 
the true association estimate in the target population that is characterized by the observed 
distribution of 𝑋 in the same population. The marginal effect of 𝐺 on 𝐷2 or 𝑍 on 𝐷2 in scenario 2 
is estimated in a similar manner as described above, except that new values of 𝑍 are generated 
after setting 𝐺 to values of 0, 1, and 2. 
 
Evaluation metrics 
The percentage bias is (?̅? − 𝜃𝑡𝑟𝑢𝑒)/?̂?𝑡𝑟𝑢𝑒 × 100, where 𝜃𝑡𝑟𝑢𝑒 is the true marginal association 
estimated by the counterfactual method and ?̅? is the average of the naïve estimates 𝜃𝑖 across
replicates, i.e., ?̅? = ∑ 𝜃𝑖/𝐵
𝐵
𝑖=1 . The coverage of the 95% confidence interval (CI) is the proportion 
of times the 95% CI 𝜃𝑖 ± 𝑍0.975𝑆𝐸(𝜃𝑖) includes 𝜃𝑡𝑟𝑢𝑒, where 𝑆𝐸(𝜃𝑖) is the estimated standard 
error for 𝜃𝑖 within each replicate and 𝑍0.975 is the 0.975 quantile of the standard normal 
distribution. We set the number of replicates 𝐵 to 5000 so that the estimated coverage of the 
95% CI should fall between 0.944 and 0.956 with 95% probability.  
 
 
 
 
 
 
 
 
 
 
	B
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Table S1. Results of the estimated hazard ratio (HR) for a genetic variant that associates 
with risk of first event, survival, and risk of a subsequent CHD event (scenario 1)  
 
 
 
The naive estimator was obtained from Cox regression. The true value was obtained from the 
counterfactual method. SE is the empirical standard error. SEE is the mean of standard error 
estimates. COV is the coverage of the 95% CI. POW is the power when exp 𝛽𝐺 ≠ 1 and the type 
1 error when exp 𝛽𝐺 = 1. Bias (%) is the difference between the estimated marginal HR and the 
true marginal HR, divided by the true marginal HR.  
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Table S2. Results of the estimated hazard ratio (HR) for a genetic variant that encodes a 
biomarker that associates with risk of first event, survival, and risk of a subsequent CHD 
event (scenario 2)  
 
 
 
The naïve estimator was obtained from Cox regression. The true value was obtained from the 
counterfactual method. SE is the empirical standard error. SEE is the mean of standard error 
estimates. COV is the coverage of the 95% CI. POW is the power when exp 𝛽𝑍 ≠ 1 and the type 
1 error when exp 𝛽𝑍 = 1. Bias (%) is the difference between the estimated marginal HR and the 
true marginal HR, divided by the true marginal HR. 𝜂 = 0.354 and 0.514 represent that 5% and 
10% variance of 𝑍 is explained by 𝐺, respectively. 
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Table S3. Results of the estimated hazard ratio (HR) for a non-genetic biomarker that 
associates with risk of first event, survival, and risk of a subsequent CHD event (scenario 
2) 
 
 
The naïve estimator was obtained from Cox regression. The true value was obtained from the 
counterfactual method. SE is the empirical standard error. SEE is the mean of standard error 
estimates. COV is the coverage of the 95% CI. POW is the power when exp 𝛽𝑍 ≠ 1 and the type 
1 error when exp 𝛽𝑍 = 1. Bias (%) is the difference between the estimated marginal HR and the 
true marginal HR, divided by the true marginal HR. 𝜂 = 0.354 and 0.514 represent that 5% and 
10% variance of 𝑍 is explained by 𝐺, respectively. 
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Table S4. Results of the estimated odds ratio (OR) for a genetic variant that associates 
with risk of first event, survival, and risk of a subsequent CHD event (scenario 1) 
 
 
 
The naïve estimator was obtained from logistic regression. The true value was obtained from 
the counterfactual method. SE is the empirical standard error. SEE is the mean of standard 
error estimates. COV is the coverage of the 95% CI. POW is the power when exp 𝛽𝐺 ≠ 1 and 
the type 1 error when exp 𝛽𝐺 = 1. Bias (%) is the difference between the estimated marginal OR 
and the true marginal OR, divided by the true marginal OR. 
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Table S5. Results of the estimated odds ratio (OR) for a genetic variant that encodes a  
biomarker that associates with risk of first event, survival, and risk of a subsequent CHD 
event (scenario 2) 
 
 
 
The naïve estimator was obtained from logistic regression. The true value was obtained from 
the counterfactual method. SE is the empirical standard error. SEE is the mean of standard 
error estimates. COV is the coverage of the 95% CI. POW is the power when exp 𝛽𝑍 ≠ 1 and 
the type 1 error when exp 𝛽𝑍 = 1. Bias (%) is the difference between the estimated marginal OR 
and the true marginal OR, divided by the true marginal OR. 𝜂 = 0.354 and 0.514 represent that 
5% and 10% variance of 𝑍 is explained by 𝐺, respectively. 
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Table S6. Results of the estimated odds ratio (OR) for a non-genetic biomarker that 
associates with risk of first event, survival, and risk of a subsequent CHD event (scenario 
2) 
 
 
 
 
The naïve estimator was obtained from logistic regression. The true value was obtained from 
the counterfactual method. SE is the empirical standard error. SEE is the mean of standard 
error estimates. COV is the coverage of the 95% CI. POW is the power when exp 𝛽𝑍 ≠ 1 and 
the type 1 error when exp 𝛽𝑍 = 1. Bias (%) is the difference between the estimated marginal OR 
and the true marginal OR, divided by the true marginal OR. 𝜂 = 0.354 and 0.514 represent that 
5% and 10% variance of 𝑍 is explained by 𝐺, respectively. 
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Table S7. Results of the estimated odds ratio (OR) for a genetic variant (scenario 1) in 
case-control studies 
 
 
The case-control design with 12500 cases and 12500 controls was adopted for populations 1, 2, 
and 3. The naïve estimator was obtained from logistic regression. The true value was obtained 
from the counterfactual method. SE is the empirical standard error. SEE is the mean of standard 
error estimates. COV is the coverage of the 95% CI. POW is the power when exp 𝛽𝐺 ≠ 1 and 
the type 1 error when exp 𝛽𝐺 = 1. Bias (%) is the difference between the estimated marginal OR 
and the true marginal OR, divided by the true marginal OR.  
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Figure S1. Illustration of different effect sizes 
                               (a)                                                                              (b)  
 
(a) The outcomes 𝐷1, 𝑆, and 𝐷2 are generated by the logistic regression models (1) and (2) and 
the proportional hazards model (3), respectively, with a conditional effect of 1.3 for the SNP of 
interest (𝐺) and a conditional effect of 10 for all remaining factors (𝑋) in all three models.  
(b) Conditioning on having the first CHD event (𝐷1 = 1, population 2), the true marginal hazard 
ratio (HR) is estimated to be 1.23 by the counterfactual method and the naïve marginal HR 
estimate is 1.15 by the standard Cox model, resulting in a bias of 6.09% towards the null; 
conditioning on both having and surviving the first CHD event (𝐷1 = 1 and 𝑆 = 1, population 3), 
the true and naïve marginal HR estimates are 1.25 and 1.12, respectively, resulting in a bias of 
10.21% towards the null. 
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Figure S2. Bias as the overall disease rate in the general population (𝒄𝟏), rate of non-
censored subsequent events (𝒄𝟐), death rate (𝒄𝑺), and SNP minor allele frequency (𝝅) vary 
 
 
All results were obtained under scenario 1 (where the genetic variant associates with risk of first 
event, survival, and risk of subsequent event) when 𝐷2 is time to event and the hazard ratios for 
𝐺 and 𝑋 are 1.3 and 10, respectively. “high mortality”: 𝑐𝑆 = 0.2. “low mortality”: 𝑐𝑆 = 0.0. “high 
first”: 𝑐1 = 0.005. “low first”: 𝑐1 = 0.002. “high subsequent”: 𝑐2 = 0.1. “low subsequent”: 𝑐2 =
0.05. For (a)-(c), 𝜋 = 0.3. For (d), 𝑐1 = 0.002 and 𝑐2 = 0.05. 
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Figure S3. Results of the estimated odds ratio (OR) for a genetic variant (scenario 1) in 
cohort and case-control studies 
 
The sample size is 25000 for both study designs. The four bars (from left to right) at each HR of 
𝐺 pertain to population 2 (selection of subjects with fatal or non-fatal first events) in cohort 
studies, population 3 (selection of subjects with non-fatal first events) in cohort studies, 
population 2 in case-control studies, and population 3 in case-control studies. The dashed line 
in the middle panel indicates the expected coverage of 0.95. The dashed line in the lower panel 
indicates the nominal significance level of 0.05. Power under the HR of 1 for 𝐺 means type 1 
error.  
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Appendix 
GENIUS-CHD Consortium full co-author list with affiliations to be supplied 
 
